Future Meat Technologies Raises $347M in Series B
Future Meat Technologies has successfully raised $347M in a Series B at a $900M valuation led by S2G Ventures, ADM Ventures.
Company Overview
Future Meat Technologies is a FoodTech company headquartered in Rehovot, Israel, founded in 2018 with 100+ employees.
Cultivated meat production
Fundraising Details
- Amount Raised: $347M
- Round Type: Series B
- Valuation: $900M
- Date: 2021-12-29
- Investors: S2G Ventures, ADM Ventures
About Future Meat Technologies
Cultivated meat production The company is positioned in the FoodTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Rehovot, Israel
- Founded: 2018
- Team Size: 100+
- Industry: FoodTech
What This Means
This funding round demonstrates strong investor confidence in Future Meat Technologies's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The FoodTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Future Meat Technologies's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $900M valuation marks an important milestone for Future Meat Technologies, positioning the company among notable players in the FoodTech industry.
Looking Ahead
With this new capital, Future Meat Technologies is well-positioned to execute on its growth strategy and continue building innovative solutions in the FoodTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2021-12-29. For more information about Future Meat Technologies, visit their headquarters at Rehovot, Israel.